Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-19-012863
Filing Date
2019-03-08
Accepted
2019-03-08 09:14:57
Documents
3
Effectiveness Date
2019-03-08

Document Format Files

Seq Description Document Type Size
1 8-K tv515762_8k.htm DEFA14A 37918
2 EXHIBIT 2.1 tv515762_ex2-1.htm EX-2.1 515947
3 EXHIBIT 99.1 tv515762_ex99-1.htm EX-99.1 17344
  Complete submission text file 0001144204-19-012863.txt   572200
Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Stellar Biotechnologies, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-37619 | Film No.: 19667743
SIC: 2834 Pharmaceutical Preparations